Cardiac lesions induced by neuroleptic drugs in the rabbit

Experimental and Toxicologic Pathology

Volumn 57, Issue 3, 2006, Pages 207-212

  Belhani, D ^a   Frassati, D ^b   Megard R ^b   Tsibiribi, P ^a   Bui Xuan, B ^a   Tabib, A ^c   Fanton, L ^c   Malicier, D ^c   Descotes, J ^d   Timour, Q ^a,d,e  

^a C H U Laboratoire de Pharmacologie   (France)

^b Centre Hospitalier Psychiatrique Le Vinatier   (France)

^c Inst Univ de Med Travail de Lyon   (France)

^d Centre de Pharmacovigilance   (France)

^e UNIVERSITÉ LYON 1   (France)

Author keywords

Cardiotoxicity; Fibrosis; Myolysis; Necrosis; Neuroleptic drugs; Rabbit; Ventricular hypertrophy

Indexed keywords

AMISULPRIDE; HALOPERIDOL; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENDOCARDIAL DISEASE; FEMALE; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HISTOPATHOLOGY; MALE; MYOCARDITIS; NONHUMAN; RABBIT;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 30344482895     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2005.09.003     Document Type: Article

References (30)

1. Y. Adachi, R. Yasumizu, and F. Hashimoto An autopsy case of giant cell myocarditis probably due to a non-steroidal anti-inflammatory drug Pathol Int 51 2001 113 117
2. M. Arthur, M.D. Feldman, and D. McNamara Myocarditis New Engl J Med 343 2000 1388 1398
3. A.E. Balant-Gorgia, M. Gex-Fabry, and C. Genet Therapeutic drug monitoring of risperidone using a new, rapid HPLC method: reappraisal of interindividual variability factors Ther Drug Monit 21 1999 105 115
4. M.A. Beck, J. Handy, and E.A. Levander The role of oxidative stress in viral infections Ann NY Acad Sci 917 2000 906 912
5. M. Davidson Risk of cardiovascular disease and sudden death in schizophrenia J Clin Psychiat 63 Suppl 9 2002 5 11
6. A.M. Feldman, and D. McNamara Myocarditis N Engl J Med 343 2000 1388 1398
7. D. Frassati, A. Tabib, and B. Lachaux Hidden cardiac lesions and psychotropic drugs as a possible cause of sudden death in psychiatric patients: a report of 14 cases and review of the literature Can J Psychiat 49 2004 100 105
8. E.K. Godeny, and C.J. Gauntt Murine natural killer cells limit coxsackie virus B3 replication J Immunol 139 1987 913 918
9. M. Hauben Sudden death in a patient taking antipsychotic drugs Postgrad Med J 75 1999 127
10. A. Henke, S. Huber, and A. Stelzner The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis J Virol 69 1995 6720 6728
11. H. Ishikawa, H. Kaneko, and H. Watanabe Giant cell myocarditis in association with drug-induced skin eruption Acta Pathol Jpn 37 1987 639 644
12. C. Kawai From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future Circulation 99 1999 1091 1100
13. S. Kongsamut, J. Kang, and X.L. Chen A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs Eur J Pharmacol 450 2002 37 41
14. A. Kumar Sudden unexplained death in a psychiatric patient - a case report: the role of phenothiazines and physical restraint Med Sci Law 37 1997 170 175
15. L. La Grenade, D. Graham, and A. Trontell Myocarditis and cardiomyopathy associated with clozapine use in the United States N Engl J Med 345 2001 224 225
16. A. Matsumori, and C. Kawai An animal model of congestive (dilated) cardiomyopathy: dilation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus Circulation 66 1982 355 360
17. P.E. McKinney, and R. Rasmussen Reversal of severe tricyclic antidepressant-induced cardiotoxicity with intravenous hypertonic saline solution Ann Emerg Med 42 2003 20 24
18. S.C. Newman, and R.C. Bland Mortality in a cohort of patients with schizophrenia: a record linkage study Can J Psychiat 36 1991 239 245
19. M. Pieroni, R. Cavallaro, and C. Chimenti Clozapine-induced hypersensitivity myocarditis Chest 126 2004 1703 1705
20. C.L. Raehl, A.K. Patel, and M. LeRoy Drug-induced torsade de pointes Clin Pharm 4 1985 675 690
21. M. Rayman The importance of selenium to human health Lancet 356 2000 233 240
22. J. Reinders, W. Parsonage, and D. Lange Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service Austr N Zeal J Psychiat 38 2004 915 922
23. D. Roesch-Ely, R. Van Einsiedel, and S. Kathofer Myocarditis with quetiapine Am J Psychiat 159 2002 1607 1608
24. R.P. Snaith Antipsychotic polypharmacy and early death Br J Psychiat 174 1999 368 369
25. S.M. Straus, G.S. Bleumink, and J.P. Dieleman Antipsychotics and the risk of sudden cardiac death Arch Intern Med 164 2004 1839
26. M.A. Tanner, and W. Culling Clozapine associated dilated cardiomyopathy Postgrad Med J 79 2003 412 413
27. K.S. Vaddadi, E. Soosai, and G. Vaddadi Low blood selenium concentrations in schizophrenic patients on clozapine Br J Clin Pharmacol 55 2003 307 309
28. W.V. Vieweg, and M.A. Wood Tricyclic antidepressants, QT interval prolongation, and torsade de pointes Psychosomatics 45 2004 371 377
29. E. Yukawa, R. Ichimaru, and T. Maki Interindividual variation of serum haloperidol concentrations in Japanese patients - clinical considerations on steady-state serum level-dose ratios J Clin Pharm Ther 28 2003 97 101
30. R.G. Zoble, E.B. Kirsten, and J. Brewington Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricular arrhythmia. Propafenone Research Group Clin Pharmacol Ther 45 1989 535 541